Allergen Profile, Perennial Allergen
Use
Detect possible allergic responses to various substances in the environment (see Test Includes) and evaluate for hay fever, asthma, atopic eczema, and respiratory allergy. The quantitative allergen-specific IgE test is indicated (1) to determine whether an individual has elevated allergen-specific IgE antibodies; (2) if specific allergic sensitivity is needed to allow immunotherapy to be initiated; (3) when testing individuals for agents that may potentially cause anaphylaxis; (4) when evaluating individuals who are taking medication (eg, long-acting antihistamines) that may interfere with other testing modalities (eg, skin testing); (5) if immunotherapy or other therapeutic measures based on skin testing results have not led to a satisfactory remission of symptoms; (6) when an individual is unresponsive to medical management where identification of offending allergens may be beneficial.
Special Instructions
The test uses Thermo Fisher ImmunoCAP® methodology and typically requires 3 to 5 days from specimen pickup to release results. Testing schedules may vary, and sometimes additional time is warranted for confirmatory tests.
Limitations
Certain labels such as improper labeling and gross hemolysis can result in specimen rejection. The test may not cover all potential allergens or reflect recent exposures. It may also not be suitable for identifying non-IgE mediated allergies.
Methodology
Immunoassay
Biomarkers
LOINC Codes
- 8251-1
- 6096-2
- 6095-4
- 6833-8
- 6098-8
- 6091-3
- 6129-1
- 6070-7
- 6100-2
- 6212-5
- 6075-6
- 6025-1
- 6182-0
- 6059-0
- 6020-2
- 6138-2
- 6029-3
- 6216-6
- 6252-1
- 6181-2
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
Not provided
Container
Red-top tube or gel-barrier tube
Storage Instructions
Room temperature
Causes for Rejection
Improper labeling; gross hemolysis
